Drug Shortage Report for XIGDUO

Last updated on 2019-04-16 History
Report ID 72331
Drug Identification Number 02449943
Brand name XIGDUO
Common or Proper name dapagliflozin and metformin hydrochloride tablets
Company Name ASTRAZENECA CANADA INC
Market Status MARKETED
Active Ingredient(s) METFORMIN HYDROCHLORIDE Dapagliflozin
Strength(s) 1000MG 5MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 6 x 10 (blister)
ATC code A10BD
ATC description BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
Reason for shortage Demand increase for the drug.
Anticipated start date 2019-01-28
Actual start date
Estimated end date 2019-02-04
Actual end date 2019-04-12
Shortage status Resolved
Updated date 2019-04-16
Company comments
Health Canada comments
Company contact information Please contact AstraZeneca Canada Medical Information for any specific questions at 1-800-668-6000 (EN) or 1-800-461-3787 (FR) or by email: medinfo.canada@astrazeneca.com.

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2019-01-15 English Compare
v2 2019-01-15 French Compare
v3 2019-01-29 English Compare
v4 2019-04-16 English Compare
v5 2019-04-16 French Compare